1 Credit™","description":"The Binaytara is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara designates this live activity for a maximum of {credit} {title}. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to {credit} hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission."},"activity_number":"","additional_info":null},{"id":375,"credit":4.5,"accreditation":{"id":4,"image":"https://imagedelivery.net/446RhcKSmHi3fzbXKA91IQ/4f570da2-09d4-45b7-2ba3-751609b94100/Icon","title":"ACPE Pharmacy","description":"$23"},"activity_number":"","additional_info":null}],"additional_tax":null,"exhibitor_link":"https://www.sponsorships.binaytara.org/SANFRANLUNG26","homepage_image":"https://imagedelivery.net/446RhcKSmHi3fzbXKA91IQ/989f4e9c-0a35-40fb-a1d8-53c3fb416800/public","additional_info":"","target_audience":"

Medical Oncologists
Surgeons
Radiation Oncologists,
Pathologists
Oncology Fellows
Oncology Nurses
Nurse Practitioners
Physician Assistants
Pharmacists

","meta_description":"","calculated_credit":null,"learning_objectives":"

Upon successful completion of this educational activity, participants will be able to:

Evaluate actionable molecular alterations in lung cancer and select appropriate diagnostic testing strategies to guide targeted treatment decisions.
Compare the efficacy, safety, and sequencing considerations of immune checkpoint inhibitors, targeted therapies, and cytotoxic chemotherapy in the management of NSCLC and SCLC.
Assess the role of perioperative and curative-intent systemic therapies in early-stage NSCLC, including chemotherapy, immunotherapy, and targeted agents.
Integrate emerging clinical evidence and advances in precision oncology into personalized treatment paradigms for patients with thoracic malignancies.

","organizing_committee":"

Course Director:

Binay Shah, MD, MHA - Binaytara

Conference Co-Chairs:

Millie Das - Stanford University
Dron Gauchan - Sutter Health
Matthew Gubens - UCSF

","price_additional_info":null,"accreditation_additonal_info":"# Acknowledgement of Commercial Support\nThis activity is supported with an Independent Medical Education grant from Gilead Sciences."},"programData":[{"id":1771266048891,"title":"Registration, Breakfast, & Exhibits ","start":"2026-05-16T14:00:00.000Z","end":"2026-05-16T15:00:00.000Z","description":null,"raw_faculty":[],"faculty":[],"type":["break"],"parentId":null,"isCmeAccredited":false},{"id":1771266072190,"title":"Welcome & Opening Remarks","start":"2026-05-16T15:00:00.000Z","end":"2026-05-16T15:05:00.000Z","description":null,"raw_faculty":[],"faculty":[],"type":["welcome"],"parentId":null,"isCmeAccredited":false},{"id":1771266090847,"title":"Progress in Targeted Therapy","start":"2026-05-16T15:05:00.000Z","end":"2026-05-16T16:35:00.000Z","description":null,"raw_faculty":[],"faculty":[],"type":["session"],"pa

Conferences

Organizing Committee:

Target Audience:

Learning Objectives: